Cargando…
New Selective Estrogen Receptor Modulators (SERMs) in Development
Selective estrogen receptor modulators (SERMs) or estrogen agonists/antagonists have shown promise in osteoporosis in that they have the potential to reduce the risk of fracture, and also reduce the risk of breast cancer. SERMs maybe classified according to their core structure, which is typically a...
Autor principal: | Silverman, Stuart L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902741/ https://www.ncbi.nlm.nih.gov/pubmed/20603714 http://dx.doi.org/10.1007/s11914-010-0025-0 |
Ejemplares similares
-
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
por: Maximov, Philipp Y, et al.
Publicado: (2013) -
Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SERMs)
por: Lephart, Edwin D, et al.
Publicado: (2022) -
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
por: Chang, Bo Yoon, et al.
Publicado: (2011) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Gennari, Luigi, et al.
Publicado: (2010) -
Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus
por: Stygar, Denis, et al.
Publicado: (2003)